about
A comprehensive review of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic TrialsBrain Painting: First Evaluation of a New Brain–Computer Interface Application with ALS-Patients and Healthy VolunteersDiagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis.Challenges assessing clinical endpoints in early Huntington disease.Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosisBiomarkers for amyotrophic lateral sclerosis.Functional classification of skeletal muscle networks. II. Applications to pathophysiology.Retinoid signaling alterations in amyotrophic lateral sclerosis.Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.The utility of independent component analysis and machine learning in the identification of the amyotrophic lateral sclerosis diseased brain.Protein biomarkers for amyotrophic lateral sclerosis.Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis.Early Detection of Huntington Disease.Prion-like mechanisms in neurodegenerative diseases.Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.Amyotrophic Lateral Sclerosis (ALS) and Related Motor Neuron Diseases: An Overview.Gene expression profile of SOD1-G93A mouse spinal cord, blood and muscle.Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis.Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor.Apparent anticipation in SOD1 familial amyotrophic lateral sclerosis.Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis.Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis.Feasibility, safety, and preliminary proof of principles of autologous neural stem cell treatment combined with T-cell vaccination for ALS patients.A Potential Biomarker in Amyotrophic Lateral Sclerosis: Can Assessment of Brain Iron Deposition with SWI and Corticospinal Tract Degeneration with DTI Help?Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)Measurement of decline of functioning in persons with amyotrophic lateral sclerosis: Responsiveness and possible applications of the Functional Independence Measure, Barthel Index, Rehabilitation Activities Profile and Frenchay Activities Index
P2860
Q26775401-AFFDDEEC-9CB6-4B2E-A9D4-89F418E8EB46Q27021917-7FAE92B6-3589-4183-A9CB-6D4E97942B83Q27500403-FAB77029-8604-4A3A-A6B0-A8E776E9B8F0Q30660585-4C31D0A6-EF21-4B2E-870B-5F1533AB1392Q34299924-397D819E-7EFB-4283-8DDC-642784CE4EECQ35726226-108E0570-4A87-4E64-981F-A57B187F5FBDQ36481118-6CA199B1-0466-4809-AC0F-7C2D84C5E15EQ36530917-40FCDAB9-33E3-4764-A54C-B83407DBF6B9Q36576439-313F0C8A-5189-49E1-88CB-C421624527B1Q36615226-F1E6AAE6-A0A5-410D-9A49-44F5254B5A69Q36914683-7EE6AC67-FB8D-45AC-9237-3359E7438283Q37157841-28F4D117-4640-4459-BC65-A83C4CC9A41BQ37209744-2A18BCF8-EBA3-449F-897B-B4DA00AE671AQ37386063-ABDE76D9-BB6D-475D-BD1C-2E8AFCC09C52Q37661351-2F5F7378-40B0-4ABF-B14C-B347CE98C470Q37951515-7FA2FBAB-88DA-44DE-98EA-8391847FCC97Q38657045-31DB57BA-DC4C-46CC-A87F-674DD9DE7E99Q39489728-C564E746-25D5-4D23-AF67-63DFF7722F27Q42668601-691637D9-53DB-4EA1-9365-B38BD69F8EDBQ45229341-A48E0A12-B1D7-45BB-9A39-58DB71419404Q45883983-A7F106BB-953C-4A29-BAF0-6FC4B514D708Q48881997-42923B77-7AB9-402B-837A-18D1294C2EEEQ50881104-9AA19760-ABF3-4E2D-8AFC-3130FC1392A9Q50950026-2E0DBFA8-95B9-42F5-BD07-FB5261325B5FQ52147637-F99D1521-F35D-43CF-9331-7CBF842DD0E4Q58125280-B2851990-98EF-4F65-BCD5-FC627FA97185Q58277707-BF66E11E-2AC6-4AA9-9BA5-8EB67F0A6827
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Measures and markers in amyotrophic lateral sclerosis.
@ast
Measures and markers in amyotrophic lateral sclerosis.
@en
type
label
Measures and markers in amyotrophic lateral sclerosis.
@ast
Measures and markers in amyotrophic lateral sclerosis.
@en
prefLabel
Measures and markers in amyotrophic lateral sclerosis.
@ast
Measures and markers in amyotrophic lateral sclerosis.
@en
P2860
P356
P1433
P1476
Measures and markers in amyotrophic lateral sclerosis.
@en
P2093
Jeremy Shefner
Muhammad Qureshi
P2860
P304
P356
10.1602/NEURORX.1.2.273
P577
2004-04-01T00:00:00Z